The pharmaceutical industry somewhat reluctantly acknowledges that topical medicines have been formulated principally for drug delivery and stability (and quite rightly so) and that features such as texture, sensorial properties and patient experience have been largely ignored. However, patient experience, be it positive or negative, strongly influences compliance and this, the industry overtly acknowledges, is critical in ensuring that clinical efficacy is achieved.
The minister of Science and Technology, Derek Hanekom, launched South Africa's Bio-economy Strategy on 14 January, which positions bio-innovation as essential to the achievement of government's industrial and social development goals.
The internationally recognised Photobiology Laboratory located at the Department of Pharmacy within the University of Limpopo’s Medunsa campus offers cosmetics product testing to determine safety and efficacy using a wide variety of methods, including SABS-approved sunscreen testing. It is ideally positioned being located on a university campus, providing easy access to interdisciplinary experience as well as multi-racial volunteer groups.
For pharmaceutical and biopharmaceutical processes, it’s important that unintentional negative impacts on cell and bacteria structures be avoided. It is for this reason that the question is raised on whether or not microwave radar level sensors kill or alter live cells in pharmaceutical processes. The debate is usually between level sensor manufacturers and drug and biodrug manufacturers, especially their cell line specialists and process developers.